Free Trial

Elixirr International (LON:ELIX) Hits New 1-Year High - Should You Buy?

Elixirr International logo with Industrials background

Elixirr International plc (LON:ELIX - Get Free Report)'s share price reached a new 52-week high on Thursday . The company traded as high as GBX 712 ($9.30) and last traded at GBX 695 ($9.08), with a volume of 22041 shares. The stock had previously closed at GBX 700 ($9.14).

Elixirr International Trading Down 0.7 %

The company has a quick ratio of 1.29, a current ratio of 1.51 and a debt-to-equity ratio of 3.90. The stock's fifty day moving average price is GBX 633.92 and its two-hundred day moving average price is GBX 596.81. The company has a market capitalization of £326.23 million, a PE ratio of 1,958.06 and a beta of 0.63.

Elixirr International Company Profile

(Get Free Report)

Elixirr International plc, through its subsidiaries, provides management consultancy services in the United Kingdom, the United States, and internationally. The company offers creative, marketing, and transformation services. It provides services in the areas of AI and machine learning, app design and development, brand identity implementation, brand strategy, business model innovation, business strategy, case for change, corporate venture and innovation, customer experience, data and analytics, data strategy, digital design and marketing, digital optimization and strategy, innovation immersions, IT strategy, mergers and acquisitions, onboarding solutions, procurement, product and portfolio management, risk and compliance, sourcing, sustainability, target operating model, and transformation management, The company serves automotive and transportation, manufacturing, business and financial services, charities, energy, utilities and resources, healthcare and pharmaceuticals, insurance, luxury and fashion, travel and leisure, telecommunications, technology, retail and consumer goods, private equity, media, and entertainment and sports industries.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Sell NVDA Now? (From Chaikin Analytics) (Ad)

Should you invest $1,000 in Elixirr International right now?

Before you consider Elixirr International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elixirr International wasn't on the list.

While Elixirr International currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Energy Vault’s 100% Stock Jump: CEO Discusses $350M Project in Australia in MarketBeat CEO Series
Market Shifts After Election: What Stocks Could Benefit Most?
Post-Election Chaos or Opportunity? Prepare Your Investments

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines